232 related articles for article (PubMed ID: 34399381)
21. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and outcomes of patients colonized with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant
Kassem A; Raed A; Michael T; Sagi O; Shimoni O; Borer A; Saidel-Odes L
Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1154-1161. PubMed ID: 32624034
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization.
Jeong IS; Song JY
Asian Nurs Res (Korean Soc Nurs Sci); 2022 Aug; 16(3):134-139. PubMed ID: 35605957
[TBL] [Abstract][Full Text] [Related]
24. Investigation on the transmission rate of carbapenemase-producing carbapenem-resistant Enterobacterales among exposed persons in a tertiary hospital using whole-genome sequencing.
Chang E; Chang HE; Shin IS; Oh YR; Kang CK; Choe PG; Park WB; Choi EH; Oh MD; Park KU; Kim NJ
J Hosp Infect; 2022 Jun; 124():1-8. PubMed ID: 35307505
[TBL] [Abstract][Full Text] [Related]
25. Rapid detection of carbapenemase-producing Acinetobacter baumannii and carbapenem-resistant Enterobacteriaceae using a bioluminescence-based phenotypic method.
van Almsick V; Ghebremedhin B; Pfennigwerth N; Ahmad-Nejad P
J Microbiol Methods; 2018 Apr; 147():20-25. PubMed ID: 29427687
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
[TBL] [Abstract][Full Text] [Related]
27. The Likelihood of Developing a Carbapenem-Resistant
Tamma PD; Kazmi A; Bergman Y; Goodman KE; Ekunseitan E; Amoah J; Simner PJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138574
[TBL] [Abstract][Full Text] [Related]
28. Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016-2018.
Paveenkittiporn W; Lyman M; Biedron C; Chea N; Bunthi C; Kolwaite A; Janejai N
Antimicrob Resist Infect Control; 2021 Jun; 10(1):88. PubMed ID: 34090537
[TBL] [Abstract][Full Text] [Related]
29. Risk Factors Associated With Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Positive Cultures in a Cohort of US Veterans.
Wilson GM; Suda KJ; Fitzpatrick MA; Bartle B; Pfeiffer CD; Jones M; Rubin MA; Perencevich E; Evans M; Evans CT;
Clin Infect Dis; 2021 Oct; 73(8):1370-1378. PubMed ID: 33973631
[TBL] [Abstract][Full Text] [Related]
30. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
31. Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.
Chea N; Bulens SN; Kongphet-Tran T; Lynfield R; Shaw KM; Vagnone PS; Kainer MA; Muleta DB; Wilson L; Vaeth E; Dumyati G; Concannon C; Phipps EC; Culbreath K; Janelle SJ; Bamberg WM; Guh AY; Limbago B; Kallen AJ
Emerg Infect Dis; 2015 Sep; 21(9):1611-6. PubMed ID: 26290955
[TBL] [Abstract][Full Text] [Related]
32. Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study.
Tang SSL; Chee E; Teo JQ; Chlebicki MP; Kwa ALH
Int J Antimicrob Agents; 2021 Jun; 57(6):106340. PubMed ID: 33857538
[TBL] [Abstract][Full Text] [Related]
33. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.
van Duin D; Arias CA; Komarow L; Chen L; Hanson BM; Weston G; Cober E; Garner OB; Jacob JT; Satlin MJ; Fries BC; Garcia-Diaz J; Doi Y; Dhar S; Kaye KS; Earley M; Hujer AM; Hujer KM; Domitrovic TN; Shropshire WC; Dinh A; Manca C; Luterbach CL; Wang M; Paterson DL; Banerjee R; Patel R; Evans S; Hill C; Arias R; Chambers HF; Fowler VG; Kreiswirth BN; Bonomo RA;
Lancet Infect Dis; 2020 Jun; 20(6):731-741. PubMed ID: 32151332
[TBL] [Abstract][Full Text] [Related]
34. Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.
Lin Q; Wang Y; Yu J; Li S; Zhang Y; Wang H; Lai X; Liu D; Mao L; Luo Y; Tang G; Chen Z; Sun Z
BMC Infect Dis; 2021 Jul; 21(1):638. PubMed ID: 34215214
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
[TBL] [Abstract][Full Text] [Related]
36. Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS.
Yu J; Liu J; Li Y; Yu J; Zhu W; Liu Y; Shen L
Ann Clin Microbiol Antimicrob; 2018 May; 17(1):22. PubMed ID: 29776363
[TBL] [Abstract][Full Text] [Related]
37. Clinical factors predicting persistent carriage of Klebsiella pneumoniae carbapenemase-producing carbapenem-resistant Enterobacteriaceae among patients with known carriage.
Kim YK; Song SA; Lee JN; Oh M; Jo KM; Kim HJ; Lee JH; Park J; Jang HJ; Kim HK; Kiem S
J Hosp Infect; 2018 Aug; 99(4):405-412. PubMed ID: 29111353
[TBL] [Abstract][Full Text] [Related]
38. Carbapenem-resistant Enterobacteriaceae: A retrospective review of treatment and outcomes in a long-term acute care hospital.
Igbinosa O; Dogho P; Osadiaye N
Am J Infect Control; 2020 Jan; 48(1):7-12. PubMed ID: 31431290
[TBL] [Abstract][Full Text] [Related]
39. Comparison of mortality rates in patients with carbapenem-resistant Enterobacterales bacteremia according to carbapenemase production: a multicenter propensity-score matched study.
Baek MS; Kim JH; Park JH; Kim TW; Jung HI; Kwon YS
Sci Rep; 2024 Jan; 14(1):597. PubMed ID: 38182719
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]